PCSK9
医学
回顾性队列研究
队列
内科学
羟甲基戊二酰辅酶A还原酶抑制剂
急诊医学
他汀类
胆固醇
低密度脂蛋白受体
脂蛋白
作者
Chi‐Hsien Huang,Shiow‐Ing Wang,Frank S. Fan,Hsueh‐Ju Lu,James Cheng‐Chung Wei
出处
期刊:European Heart Journal - Cardiovascular Pharmacotherapy
[Oxford University Press]
日期:2024-07-25
标识
DOI:10.1093/ehjcvp/pvae056
摘要
PCSK9 inhibitors are effective in reducing cardiovascular events, but their impact on all-cause mortality and medical utilization compared to statins is unclear. This study investigated PCSK9 inhibitor use and its impact on mortality and medical utilization versus statins, using TriNetX database data with up to 9 years of follow-up.
科研通智能强力驱动
Strongly Powered by AbleSci AI